Accelerated telomere shortening in rheumatic diseases: cause or consequence?

Area of Science:

• Immunology
• Rheumatology
• Gerontology

Background:

• Accelerated immune aging, characterized by telomere shortening, is increasingly recognized in rheumatic diseases.
• Existing research on telomere length in rheumatic conditions presents conflicting findings.
• Immune aging may play a significant role in the pathogenesis of various immune-mediated conditions.

Purpose of the Study:

• To review the current literature on the role of immune aging in rheumatic diseases.
• To investigate the relationship between telomere shortening and immune-mediated conditions such as systemic sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and osteoarthritis.
• To determine whether rheumatic diseases precipitate accelerated aging or vice versa.

Main Methods:

• Systematic literature review of studies investigating immune aging and telomere length in rheumatic diseases.
• Analysis of data from studies on systemic sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and osteoarthritis.
• Synthesis of evidence to evaluate the causal relationship between immune aging and rheumatic disease development.

Main Results:

• Telomere shortening is a common feature observed in several rheumatic diseases, indicating immune aging.
• The extent and significance of telomere shortening vary across different rheumatic conditions.
• Evidence suggests a complex interplay where immune aging might contribute to the onset or progression of rheumatic diseases, and potentially be exacerbated by them.

Conclusions:

• Immune aging, evidenced by telomere shortening, is significantly associated with rheumatic diseases.
• The review highlights the need for further research to elucidate the causal direction: does immune aging drive rheumatic diseases, or do these diseases accelerate immune aging?
• Understanding this relationship is crucial for developing targeted therapies for immune-mediated inflammatory diseases.